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A B S T R A C T
The quantized vibration of chemical bonds provides a way of detecting speciﬁc molecules in a complex
tissue environment. Unlike pure optical methods, for which imaging depth is limited to a few hundred
micrometers by signiﬁcant optical scattering, photoacoustic detection of vibrational absorption breaks
through the optical diffusion limit by taking advantage of diffused photons and weak acoustic scattering.
Key features of this method include both high scalability of imaging depth from a few millimeters to a few
centimeters and chemical bond selectivity as a novel contrast mechanism for photoacoustic imaging. Its
biomedical applications spans detection of white matter loss and regeneration, assessment of breast
tumor margins, and diagnosis of vulnerable atherosclerotic plaques. This review provides an overview of
the recent advances made in vibration-based photoacoustic imaging and various biomedical applications
enabled by this new technology.
ã 2016 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
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Fig. 1. Schematic of vibration-based PA signal generation and the 1st and 2nd
overtone absorption of a molecule. v denotes the vibrational energy level; NIR
demotes near infrared.
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Molecular vibration is the basis of numerous microscopy
approaches and enables the detection of speciﬁc molecules within
cells and tissues. These approaches include Raman scattering,
infrared absorption, and near-infrared (NIR) absorption, which
have been widely used for chemical imaging in biomedicine [1–3].
Similarly, nonlinear vibrational methods, such as coherent anti-
Stokes Raman scattering [4,5] and stimulated Raman scattering [6]
microscopies, have enabled new discoveries in biology [7] on
account of their high sensitivity and 3D spatial resolution.
However, all these approaches have limited imaging depth on
the order of a few hundred micrometers due to signiﬁcant optical
scattering in biological tissue. Thus, their potential applications at
the organ level in vivo and in clinical settings are restricted.
A deep-tissue imaging modality able to maintain both high
chemical selectivity and spatial resolution would certainly satisfy
the functional requirements for many diagnostic applications in
biomedicine. A promising approach is the development of photo-
acoustic (PA) imaging platforms, which combine optical excitation
with acoustic detection. With this approach, the imaging depth is
signiﬁcantly improved, as acoustic scattering by biological tissue
(1.2  103mm1 in human skin at 5 MHz) [8] is more than three
orders of magnitude weaker than optical scattering (10 mm1 in
human skin at 700 nm) [9]. Unlike nonlinear optical microscopy
that relies on tightly focused ballistic photons, the diffused
photons contribute equally to the generation of PA signal and
thus further enhance the penetration depth. Over the past decade,
researchers have developed various PA imaging platforms,
including photoacoustic microscopy (PAM) [10,11], photoacoustic
tomography (PAT) [10,12,13], photoacoustic endoscopy (PAE)
[14,15], and intravascular photoacoustic (IVPA) imaging [16]. Many
excellent review articles provide comprehensive insight into
different aspects of the imaging technology [17–19], applicable
contrast agents [20–22], and a variety of biomedical applications
[23–26]. In most of the aforementioned applications, the PA signal
comes from the electronic absorption of endogenous tissue
pigments, such as hemoglobin and melanin, or from exogenous
contrast agents, such as nanoparticles and dyes.
Molecular vibrational transitions in biological tissue have
recently been demonstrated as a novel contrast mechanism for
PA imaging. It describes the periodic motion of atoms in a molecule
with typical frequencies ranging from 1012 to 1014Hz. The
molecular population in the ith vibrationally excited state relative
to the ground state follows the Boltzmann’s distribution law as
Ni/N0= exp(DE/kT), where DE is the energy gap, T is the
temperature, and k is the Boltzmann constant. Thus, the Boltzmann
distribution describes how the thermal energy is stored in
molecules. When the incident photon energy matches the
transition frequency between the ground state and a vibrationally
excited state, the molecule absorbs the photon and jumps to the
excited state. During subsequent relaxation of the excited molecule
to the ground state, the thermal energy is converted into acoustic
waves detectable by an ultrasound transducer.
The fundamental vibrational transitions in the mid-infrared
wavelength region have been previously exploited for PA detection
of glucose in tissues [27]. Nevertheless, this approach is limited in
detecting molecules only tens of micrometers under the skin,
where strong water absorption in the mid-infrared region
predominates. Vibrational absorption with minimal water absorp-
tion can occur in two ways. One is through the stimulated Raman
process and the other is through overtone transition. In stimulated
Raman scattering, the energy difference between the visible or NIR
pump and Stokes ﬁelds is transferred to the molecule to induce a
fundamental vibrational transition. The concept of stimulated
Raman-based PA imaging has been previously demonstrated[28,29]. However, because stimulated Raman scattering is a
nonlinear optical process relying on ballistic photons under a
tight focusing condition, this approach is not suitable for deep-
tissue imaging. The overtone transition is based on the anharmo-
nicity of chemical bond vibrations. Taking the CH bond as an
example, the ﬁrst, second, and third overtone transitions occur at
around 1.7 mm, 1.2 mm, and 920 nm, respectively, where water
absorption is locally minimized. Since CH bonds are one of the
most abundant chemical bonds in biological molecules including
lipids and proteins, photoacoustic detection of CH bond overtone
absorption offers an elegant platform for mapping the chemical
content of tissue with penetration depths up to a few centimeters.
In the following sections, we introduce the mechanism for
vibration-based PA signal generation. Then, applications of
vibration-based PA imaging in forms of microscopy, tomography,
and intravascular catheter will be reviewed, followed by a
discussion of the improvements needed to overcome technical
challenges that limit translation of these imaging modalities to the
clinic.
2. Vibrational absorption as a photoacoustic contrast
mechanism
2.1. Photoacoustic signal generation based on molecular overtone
absorption
Vibration-based PA signals arise from the molecular overtone
transitions and combinational band absorptions, which are
allowed by anharmonicity of chemical bond vibration. According
to the anharmonicity theory, the transition frequency for an
overtone band has the following relation with the fundamental
frequency, Vn = V0n-xV0(n + n2), where V0 is the transition
frequency of fundamental vibration, x is the anharmonicity
constant, and n = 2,3 . . . representing the ﬁrst, second, and
subsequent overtones. When the frequency of an incident pulsed
laser matches the transition frequency of an overtone, the energy
of the incident photons is absorbed and then induces a local rise in
temperature. When both thermal and stress conﬁnements are
satisﬁed [30], the accumulated heat is subsequently released
through a thermal-elastic expansion in tissue, which generates
acoustic waves detectable by an ultrasound transducer. Fig. 1
depicts this process for PA signal generation based on ﬁrst and
second overtone transitions. The generated signal contains depth-
resolved information of absorbers on which the image
Table 1
Absorption coefﬁcient and Gruneisen parameter of fat and water at 1.2 and 1.7
micron.
Tissue constituent Tissue parameter 1210 nm 1730 nm Ref.
Fat ma (cm1) 1.65 10.5 [54]
G 0.7–0.9 0.7–0.9 [56]
Water ma (cm1) 1.00 5.63 [53]
G 0.12 0.12 [9]
J. Hui et al. / Photoacoustics 4 (2016) 11–21 13reconstruction is grounded. Compared to diffuse optical tomogra-
phy, the integration of NIR spectroscopy with ultrasound detection
eliminates the scattering background.
Through conversion of molecular vibration into acoustic waves,
vibration-based PA imaging enables the visualization of different
molecules and chemical components in biological tissue. Thus far,
CH2-rich lipids [31–36], CH3-rich collagen [33], OH bond-rich
water [37], nerve [38,39], intramuscular fat [34,40], and neural
white matter [41] have all been investigated. Particularly, the
detection of overtone absorption of CH bonds has recently
drawn attention [42–48], since CH bonds are highly concentrat-
ed in certain types of biological components, such as lipid and
collagen. The presence of these molecules or components is
directly related to several clinically relevant diseases, including
atherosclerosis and cancers.
2.2. New optical windows for photoacoustic imaging
Using vibrational absorption, researchers have conducted PA
spectroscopic studies of various molecules in biological specimens
[31,34,35,49]. These efforts were aimed at identifying suitable
spectral windows to visualize different biological components, as
well as differentiate them based on their vibrational spectral
signatures. As shown in Fig. 2a, two new optical windows have
been identiﬁedfor bond-selective photoacoustic imaging (highlight-
ed in blue between 1100–1300 nm and 1650–1850 nm), where the
absorption coefﬁcient of CH bond-rich specimens is maximized
and water absorption is locally minimized. The electronic absorption
of hemoglobin [50] is dominant in the visible to NIR wavelength
range (i.e., 400 nm to 1.1 mm) and it overwhelms the third- and
higher-order CH overtone transitions in the same range. ForFig. 2. Two spectral windows for vibration-based PA imaging. (a) Optical absorption s
deoxygenated (Hb) (from Ref. [50]) showing that the ﬁrst optical window lies between 1
based PA spectra of different chemical bonds or groups with absorption band assignment
bond, respectively. (b) Vibration-based PA spectra of a CH bond-rich sample (polyethy
[34] (b, c).longer wavelengths in the range of 1.1–2.0 mm, the optical
absorption from hemoglobin has been signiﬁcantly reduced. In
particular, in the ﬁrst optical window, the hemoglobin absorption
[50] is close to one orderof magnitude smaller than lipid absorption.
The whole blood in the second optical window (1650–1850 nm)
exhibits almost the same spectrum as pure water [50], the major
content of blood [51–53]. Although the absorption coefﬁcient of
lipid [54,55] is 1–2 time larger than that of water in both optical
windows, the fat constituent in tissue provides much higher
contrast than water in vibration-based PA imaging. This observed
phenomenon in PA imaging experiments can be explained by the
following theoretical prediction and quantitative analysis.
Theoretically, the initial PA signal amplitude is described by p0 =
jG maF, where j is a constant related to the imaging system, G is
the Gruneisen parameter of tissue, ma is the absorption coefﬁcient
of tissue, and F is the local light ﬂuence. The Gruneisen parameter
can be further expressed as G =bns2/Cp, where b is the isobaric
volume expansion coefﬁcient, ns is the acoustic speed, and Cp is the
speciﬁc heat. In the equation, only G and ma are dependent on
absorbers in tissue. Thus, the vibration-based PA contrast of
fat versus water can be expressed as p0_fat/p0_water = (maG )
fat/(maG )water. Based on the Gruneisen parameter and absorptionpectra of water (from Ref. [53]), lipid (from Refs. [54,55]), oxygenated (HbO2) and
.1 and 1.3 mm and the second window lies between 1.65 and 1.85 mm. (b) Vibration-
s. ns and na denote symmetric stretching and anti-symmetric stretching of chemical
lene ﬁlm) with a varying water layer thickness. Adapted with permission from Ref.
14 J. Hui et al. / Photoacoustics 4 (2016) 11–21coefﬁcient of fat and water listed in Table 1 [9,54,56], the PA
contrast of fat versus water is 9.6–12.4 and 10.9–14.0 at 1210 and
1730 nm, respectively. These parameters make vibration-based PA
imaging a valid platform for selective mapping of fat or lipids in a
complex tissue environment. Based on the same parameters, the
fat signal amplitude at 1730 nm is 6.4 time of that at 1210 nm,
largely due to the stronger absorption of lipid at 1730 nm.
Detailed analysis of the PA spectra of CH, OH, and OD
bonds further veriﬁed these two optical windows [57]. Fig. 2b
shows the PA spectra of polyethylene ﬁlm, trimethylpentane,
water, and deuterium oxide. These spectra have contributions from
the absorption proﬁles of methylene groups (CH2), methyl groups
(CH3), OH, and OD bonds, respectively. According to the
spectrum of polyethylene ﬁlm, the peak at 1210 nm comes from
the second overtone transition of the symmetric stretching of CH2
[58]. The broad peak located from 1350 to 1500 nm is attributed to
the combinational band of symmetric stretching and bending of
CH2. The two primary peaks at 1.7 mm are thought to be the ﬁrst
overtone of CH2 [58], which are caused by the anti-symmetric
stretching and symmetric stretching, respectively [58]. For
trimethylpentane, the 1195 nm peak corresponds to the second
overtone transition of CH3 symmetric stretching [58]. The
combinational band has a main peak at 1380 nm [58]. The
primary peak at 1700 nm is thought to be the ﬁrst overtone of
anti-symmetric stretching of CH3 [58]. Although OH bonds haveFig. 3. A PAM system and enabled representative applications enabled in the new optic
image of lipid bodies in Drosophila 3-instar Larva at 1200 nm. (c) Image of intramuscula
rat spinal cord at 1730 nm showing the contrast difference between white matter and gra
Adapted with permission from Ref. [31] (a, b), Ref. [40] (c), and Ref. [41] (d).combinational bands at 1450 and 1950 nm, respectively, its
absorption is locally minimal in the ﬁrst and second overtone
windows of CH bonds. Due to the heavier mass of deuterium, the
prominent overtone and combinational bands of D2O have their
corresponding peaks at longer wavelengths. Thus, it has been
widely used as an acoustic coupling medium for vibration-based
PA imaging [34,57].
As shown in Fig. 2c, a PA spectroscopic study of polyethylene
ﬁlm with a varying water layer thickness suggests that the second
overtone of CH bonds is peaked at 1.2 mm, while the ﬁrst
overtone corresponds to the peak at 1.7 mm [34]. Compared with
1.2 mm excitation, 1.7 mm excitation produces a 6.3 times
stronger PA signal in the absence of water [34], which is consistent
with aforementioned theoretical calculation. The signal amplitude
drops with the thickness of the water layer and has the same level
as 1.2 mm excitation when the water layer thickness reaches
3–4 mm. Thus, a 1.7 mm wavelength is favorable for intravascular
photoacoustic imaging considering the relatively large absorption
coefﬁcient of the ﬁrst overtone and the diminished optical
scattering caused by blood at longer wavelengths [36,47,52,57].
The second overtone however is suitable for a tomographic
conﬁguration that requires larger penetration depths due to
smaller water absorption at 1.2 mm [59]. These spectral signatures
were utilized for different biomedical applications, as reviewed
below.al windows. (a) Schematic of a typical PAM system. T, ultrasound transducer. (b) 3D
r fat at 1197 nm performed with a Raman laser. (d) Image of white matter in a normal
y matter. Red arrows indicate the dorsolateral surface of the cord above dorsal horn.
J. Hui et al. / Photoacoustics 4 (2016) 11–21 153. Applications through vibration-based photoacoustic
microscopy
Based on its high spatial resolution, deep penetration depth,
and rich optical absorption contrast, PAM has been used
extensively and enabled new discoveries in biology and medicine.
Using vibrational absorption, new applications are explored
through PAM in the relevant optical windows. In a typical PAM
setup, an inverted microscope is employed to direct the excitation
light (Fig. 3a) which can be generated by Nd:YAG pumped optical
parametric oscillator (OPO) [31,38,60] or a Raman laser [40]. An
achromatic doublet lens or objective is applied to focus the laser
light into a sample. A focused ultrasonic transducer records the
time-resolved PA signal from the acoustic focal zone. According to
the time of ﬂight, each laser pulse can be used to generate an A-
line. By raster scanning the sample in the X–Y direction, a three-
dimensional image can be acquired.
3.1. Mapping lipid bodies in Drosophila 3rd-instar larva
One important application for PAM in the new optical windows
is to map the lipid bodies in Drosophila 3rd-instar Larva.Fig. 4. A PAT system and enabled representative applications enabled in the new optical w
US, ultrasound. (b) Images of modeled atherosclerotic carotid artery with contrast from lip
(d) Image of breast tumor margin with contrast from fat and blood. Red oval indicate
angiogenesis and invasive tumor with scattered fat tissue; blue oval indicates tumor with
Ref. [39] (c).Drosophila melanogaster is one of the genetically best-known
and widely used model organisms for genetic, behavioral,
metabolic, and autophagic studies [61–63]. Since lipids have
strong optical absorption due to the second overtone transition of
the CH bond, Wang et al. performed 3D imaging of lipid body of a
whole 3rd-star larva in vivo (Fig. 3b). The imaging result shows that
lipid storage is mainly distributed along the anterior-posterior and
the ventral-dorsal axis. This demonstrated capability of label-free
visualization of adipose tissues in Drosophila is important for the
rapid determination of phenotype, which will decrease the time
required to conduct genetic screens for targets of fat metabolism
and autophagy in this model organism [64,65].
3.2. Mapping intramuscular fat
Intramuscular lipids are associated with insulin resistance,
which is related to a range of metabolic disorders including type
2 diabetes, obesity, and cardiovascular diseases [66,67]. However,
the assessment of intramuscular fat is difﬁcult since current deep-
tissue imaging modalities cannot provide chemical contrast. Li
et al. reported the feasibility of performing intramuscular fat
mapping with a Ba(NO3)2 crystal-based Raman laser [40]. Theindows. (a) Schematic of a typical PAT system. OPO, optical parametrical oscillator;
id and blood. (c) Images of mouse peripheral nerve with contrast from fat and blood.
s a normal tissue area with fat and scattered ﬁbrous tissue; yellow oval indicates
 dense ﬁbrous tissue. Adapted with permission from Ref. [90] (a, d), Ref. [78] (b), and
16 J. Hui et al. / Photoacoustics 4 (2016) 11–21Raman laser provided an output with wavelength of 1197 nm. The
signal from fat at 1197 nm is strong and the contrast nearly
disappeared at 1064 nm, which indicates a strong absorption at
1197 nm due to the second overtone transition of CH bond. The
muscle sample was also imaged in three dimensions with an
imaging depth of 3 mm, where the fat structure was clearly
reﬂected (Fig. 3c). This result shows the promise of using this
technique for quantitative measurement of intramuscular fat
accumulation in metabolic disorders.
3.3. Mapping white matter loss and regeneration
Each year, approximately 12,000 new cases of spinal cord injury
are diagnosed in the U.S., causing tetraplegia or paraplegia. White
matter loss is thought to be a critical event after spinal cord injury.
Traditionally, such degeneration is measured by histological and
histochemical approaches [68]. However, real-time imaging is not
feasible and artifacts are often introduced during histological
processing. Wu et al. used PAM with 1730 nm excitation to assess
white matter loss after a contusive spinal cord injury in adult rats
[41]. Owing to the abundance of CH2 groups in the myelin sheath,
white matter in the spinal cord can be easily visualized (Fig. 3d).
From the cross-sectional image, contrast from white matter is 2.5
times higher compared with grey matter. The absorption differ-
ence can be used to examine the morphology of white matter and
changes in injured spinal cords. This study suggests that PAM based
on ﬁrst overtone transition of CH bond could be potentially used
to assess white matter loss during spinal cord injury and repair.
4. Applications through vibration-based photoacoustic
tomography
By taking advantage of signal generation from diffused photons,
PAT penetrates deeper than PAM and expands the imaging scale
from the cell and tissue to whole organ level [13]. The high
scalability of PAT is achieved through a trade-off in spatial
resolution for improved imaging depth. Moreover, the imaging
scale can vary with the speciﬁc needs of PAT applications. Current
applications for PAT include lymphatic [69] and sentinel lymph
node [70,71] mapping, superﬁcial [72] and deep [73] vessel
mapping, and tumor imaging [74,75]. The key advantages of this
technique are noninvasiveness, superior depth penetration, and
chemical-selectivity without the need for exogenous agents. For
superior penetration depth, the experimental set-up requires
integration of a high power laser with a low-frequency ultrasound
array. Fig. 4a shows a typical PAT system [39]. Brieﬂy, a customized
OPO laser (NT352C, EKSPLA) generating a 10 Hz, 5 ns pulse train
with wavelength tunable from 670 to 2300 nm was used as the
light excitation source. An optical ﬁber bundle delivers the light to
tissue through two rectangular distal terminals adjacent to an
arrayed ultrasound transducer with center frequency of 21 MHz
(MS250, FUJIFILM VisualSonics). The generated PA signal is then
acquired and reconstructed as two-dimensional or three-dimen-
sional tomographic images using the ultrasound system. Below we
describe a range of applications using molecular overtone
absorption for tomographic imaging of lipid-associated diseases.
4.1. Imaging a model of carotid atherosclerosis
Carotid artery atherosclerosis is a common underlying cause of
ischemic stroke [76,77]. Noninvasive imaging and quantiﬁcation of
the compositional changes within the arterial wall is essential for
disease diagnosis. Current imaging modalities are limited by the
lack of compositional contrast, inability to detect of non-ﬂow-
limiting lesions, and inadequate accessibility to patients (like
magnetic resonance imaging). However, modiﬁed multispectralPAT has great potential for serving as a point-of-care device for
early diagnosis of carotid artery disease in the clinic. Hui et al.
tested this system to image ex vivo atherosclerotic human femoral
arteries and tissue-mimicking phantoms [78]. We placed a
45-degree polished ﬁber-optic probe and a 21 MHz linear array
transducer with 256 elements on opposite sides of the sample with
a thick piece of chicken breast in order to mimic the in vivo
conditions of carotid artery imaging through transesophageal
excitation and external acoustic detection. Chemical maps of the
blood and lipid in the lipid-laden vessel and fatty chicken breast
were generated as shown in Fig. 4b.
Furthermore, for the tissue-mimicking phantom experiment, a
piece of chicken breast was added between the excitation source and
a polyethylene tube in order to analyze the signal-to-noise ratio and
imaging depth in this set-up. An imaging depth of about 2 cm was
achievable in this scenario while retaining chemical selectivity
around 1210 nm and spectral discrimination (<10 nm) between the
intramuscular fat in the chicken breast and the polyethylene tube.
These results collectively show that this prototype ﬁber-optic probe
design enables deep-tissue multispectral imaging and has transla-
tional potential as a minimally invasive diagnostic tool.
4.2. Imaging peripheral nerves
In a surgical procedure, iatrogenic damage to peripheral nerves
is a leading cause of morbidity [79–81]. The resultant complica-
tions include temporary numbness, loss of sensation, and
peripheral neuropathy [80,82]. The accurate noninvasive visuali-
zation of nerve tissues relative to adjacent structures is of vital
importance yet remains technically challenging. As myelin sheaths
surrounding axons are abundant in lipids, there is an opportunity
to apply PA imaging technique to discriminate nerves from
adjacent tissues using lipid and blood as two different contrasts.
A preliminary feasibility study of nerve imaging was performed
in a PAM conﬁguration [38]. Clinical translation of this technique
however is impeded by millimeter-scale imaging depth and slow
imaging speed. Li et al. recently demonstrated the label-free in vivo
tomographic visualization of mouse nerves through PAT based on
second overtone absorption of CH bonds with an imaging depth
of at least 2 mm [39]. Spectroscopic imaging was performed in the
optical window of 1100 to 1250 nm to discriminate lipid
(1210 nm) from blood (<1150 nm). An algorithm called multivar-
iate curve resolution alternating least squares (MCR-ALS) [83] was
then applied to the spectroscopic image stack to resolve chemical
maps from lipid and blood. As shown in Fig. 4c, the femoral nerve
ﬁber was clearly resolved and distinguished from the adjacent
femoral artery. Although this application does not require a greater
imaging depth, it demonstrates chemical selectivity (using only
two excitation wavelengths) and sufﬁcient spatial resolution to
discriminate adjacent structures with a large imaging ﬁeld of view.
It has the potential for label-free imaging of peripheral nerves in
patients undergoing surgery.
4.3. Assessing breast tumor margins
Breast-conserving surgery, or lumpectomy, is a common
procedure for breast cancer treatment [84,85]. To prevent local
cancer recurrence after lumpectomy, histology is performed to
check whether the excised tumor specimen is surrounded by a
sufﬁcient amount of normal tissue [86,87]. A re-operation is
needed if a positive margin is identiﬁed. Currently, the re-
operation rate ranges from 20% to 70% [88,89]. This high re-
operation rate highlights a pressing need for the development
of an intraoperative device that is rapid, sensitive, label-free,
and able to scan the entire tissue surface for accurate breast
cancer margin assessment.
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contrast provides a compelling opportunity to meet this need [90].
Speciﬁc to breast cancer, multispectral PAT, as shown in Fig. 4a, was
applied for margin detection in the optical window from 1100 to
1250 nm. In this window, the distribution of fat and blood were
visualized after acquisition of a multispectral image stack. The image
stack was processed through the MCR-ALS algorithm, generating
chemical maps for those two major components (Fig. 4d). Based on
the imaging results and a comparisonwith histology results, the area
with fat and lacking hemoglobin contrast was assigned to be normal
tissue with fat and scattered ﬁbrous tissue (red oval). The area with
hemoglobin contrast and fat indicated angiogenesis and invasive
tumor with scattered fat tissue (yellow oval). The area without fat
contrast indicated tumor tissue with dense ﬁbrous tissue (blue oval).
These results collectively demonstrated the capacity of tumor
margin assessment based on the contrast of hemoglobin and fat. This
imaging conﬁguration maintains an imaging depth of up to 3 mm,
which is sufﬁcient for determining breast tumor margins (typically
1–2 mm of tumor-free tissue are necessary for a margin to be
negative). With 100% sensitivity, the system can successfully detect
breast tumor margin and opens a new way for clinical intraoperative
breast tumormargin assessment. A similarapproach using bloodand
lipid as two complementary contrasts has recently been demon-
strated to visualize the vasculature and external boundaries of
healthy lymph nodes across theirdepth (<6 mm) [91]. Future studies
willbeuseful for “indirectdetection” ofcancerous nodes inwhichthe
structure and composition are expected to change.
5. Intravascular photoacoustic imaging of lipid-laden plaques
Beyond microscopic studies of lipid-laden plaques inside an
atherosclerotic artery, IVPA has been intensively investigated over
the past few years. As is widely known, cardiovascular disease is
the number one cause of death in the United States. The majority of
acute fatal incidents with cardiovascular disease are due to
vulnerable plaques, which are at a high risk for rupture andFig. 5. IVPA/IVUS imaging of lipid-laden atherosclerotic plaque. (a) IVPA/IVUS imaging 
with Oil Red O stain; IVUS image; IVPA image at 1210 nm (high lipid absorption); IVP
arrowheads, a needle used for marking. (b) IVPA/IVUS imaging of an excised human fem
indicating large lipid deposition; IVUS image. Adapted with permission from Ref. [32] thrombosis [92,93]. Pathophysiological ﬁndings suggest that these
vulnerable lesions contain a large lipid core covered by a thin
ﬁbrous cap and are located in areas of high shear stress within the
coronary arterial wall [94,95]. Current imaging modalities either
lack compositional contrast or sufﬁcient imaging depth for this
application. Furthermore, no existing imaging tools can reliably
and accurately diagnose vulnerable plaques in live patients [96].
However, IVPA maintains high resolution, chemical selectivity, and
sufﬁcient imaging depth to characterize vulnerable plaques. It has
great potential to be developed as a life-saving device for diagnosis
of vulnerable plaques.
5.1. Imaging lipid-laden atherosclerotic plaques
The current translational goal for IVPA imaging is to detect
lipid-laden plaques with high accuracy and speciﬁcity. Thus, the
selection of an optimal wavelength to excite lipids becomes the
primary objective. PA imaging of lipid-rich plaques has been
demonstrated using different wavelengths [35,97,98]. However,
the PA signal from lipids between 400 and 1100 nm is greatly
overwhelmed by hemoglobin absorption, and is not suitable for in
vivo applications. When the wavelength exceeds 1.1 mm, hemo-
globin absorption is minimal, but signiﬁcant water absorption due
to vibrational transition of OH bonds attenuates light intensity
inside the biological tissue. Nevertheless, two optical windows
have been revealed for PA detection of overtone absorption of CH
bonds, where lipids can be imaged at 1.2 mm and 1.7 mm as
discussed before [31,36,44].
Grounded on these two lipid-speciﬁc optical windows, a series
of IVPA imaging developments has been reported. Jansen et al.
demonstrated the ﬁrst IVPA imaging result of human artery with
1210 nm excitation of the second overtone of CH bond [32]. As
seen in Fig. 5a, the histology shows a large eccentric lipid-rich
lesion, as well as a calciﬁed area and regions of peri-adventitial fat,
which is conﬁrmed by IVUS image. The IVPA image at 1210 nm
exhibits a bright signal along the intimal border, and also fromof an advanced human atherosclerotic plaque in 1.2 mm optical window: histology
A image at 1230 nm (low lipid absorption). *, lipid-rich plaque; Ca, calciﬁed area;
oral artery in 1.7 mm optical window: IVPA image at 1724 nm with white arrows
(a) and Ref. [99] (b).
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adventitial fat in the bottom right corner, compared with IVPA
image at 1230 nm. Wang et al. tested the feasibility of IVPA imaging
of atherosclerotic rabbit aorta at 1.7 mm in the presence of luminal
blood [36]. A preliminary study of in vivo IVPA imaging was also
performed at 1720 nm in a rabbit model [43]. These results suggest
that in vivo IVPA imaging is possible even without ﬂushing luminal
blood with saline, a necessary step for imaging coronary arteries
with optical coherence tomography. Recently, with the availability
of high-repetition-rate laser sources, a few research groups have
developed high-speed IVPA imaging at 1.7 mm [99–101]. Hui et al.
demonstrated the high-speed IVPA imaging of human femoral
artery ex vivo at 1 frame per sec as shown in Fig. 5b [99]. The IVPA
and IVUS images of the atherosclerotic artery reveal complemen-
tary information in the artery wall. The lipid deposition in the
arterial wall indicated by white arrows at 2 and 3 o'clock
directions, which is not seen in the IVUS image, shows clear
contrast in the IVPA image.
5.2. High-speed laser sources
IVPA imaging has been widely considered a promising technique
for the diagnosis of vulnerable plaque in the arterial wall of live
patients. However, the translation of the imaging technology from
bench to bedside has been stiﬂed by its slow imaging speed, mainly
due to lack of suitable laser sources to excite the molecular overtone
transitions at a high repetition rate. Wang et al. recently
demonstrated a 2-kHz master oscillator power ampliﬁer (MOPA)-
pumped barium nitrite (Ba(NO3)2) Raman laser, which enabled the
high-speed IVPA imaging [47]. In the laser system, a 1064 nm pulsed
laser at a repetition rate of 2 kHz generated by the MOPA laser was
used to pump the Ba(NO3)2-based Raman shifter (Fig. 6a). Through a
stimulated Raman scattering process, the 1064 nm pump laser is
converted to an 1197 nm output, which matches the second overtone
vibration of CH bond and thus can be used to excite the lipid-rich
plaques. The high-speed IVPA imaging with this laser was validated
using the iliac artery from a pig model at a speed of 1 frame per sec,
which is nearly two orders of magnitude faster than previously
reported systems.Fig. 6. High-repetition-rate laser sources developed for IVPA imaging. (a) Schematics of 2
hole; QR: quartz rotator; OI: optical isolator; FA: ﬁber ampliﬁer; DL: Directly modulate
splitter; HWP: half wave plate; M8: resonator end mirror; M9: output coupler; M10: silver 
M2, M5, M6, ﬂat mirrors; M3, M4, M8, reﬂective mirrors; M7, dichroic mirror; KD*P, potassi
shows the pictures of the actual laser system. Adapted with permission from Ref. [47]Since 1.7 mm optical window is more optimal for in vivo IVPA
imaging when compared with 1.2 mm, the laser development
having output at 1.7 mm with high pulse energy and high
repetition rate is of great importance toward the in vivo
applications of IVPA imaging. More recently, several research
groups have developed such laser sources based on different
technologies with a repetition rate of kHz levels and applied them
to high-speed IVPA imaging [99–101]. As one example, shown in
Fig. 6b, a potassium titanyl phosphate (KTP)-based OPO laser has
an output at 1724 nm with pulse energy up to 2 mJ and with pulse
repetition rate of 500 Hz [99]. In order to obtain high pulse energy
at high repetition rate, two KTP crystals were cut with a special
angle and placed with adverse orientation in the OPO, which
effectively minimized the walk-off effect. This laser enabled
imaging of human artery at a speed of 1 frame per sec with a
cross-sectional IVPA image composed of 500 A-lines. This speed
greatly reduces the ambiguity caused by slow imaging speed and
can be further used for preclinical in vivo imaging. However, in
order to make IVPA competitive in the clinic, the repetition rate
needs to be further improved to the order of 10 kHz [99].
6. Discussion
Harnessing its high depth scalability and endogenous contrast
mechanism, vibration-based PA imaging has opened up a range of
biomedical applications in forms of microscopy, tomography, and
intravascular imaging, as well as technical challenges for their
translation to the clinic. PAM with overtone absorption of CH
bonds as the contrast can achieve ultrasonic resolution in deep
tissue regime. As lipids are rich in CH2-groups, PAM offers
opportunities for lipid imaging, which is often related to disease
severity, including type 2 diabetes and white matter loss and
regeneration. Using an OPO as the light exciting source,
multispectral PAM can be achieved with spectral signatures of
molecules. Currently, with 20 MHz ultrasound transducer, the
lateral resolution of vibration-based PAM is 70 mm [31].
However, it potentially can be increased by 10 times with
optical-resolution PAM conﬁguration through a 75 MHz trans-
ducer and objective lens [102]. Because of light focusing and kHz MOPA-pumped Raman laser with an output of 1197 nm. Amp: ampliﬁer; PH: pin
d diode laser; M1–M7: 45-degree 1064 nm reﬂective mirror; PBS: polarizing beam
mirror. (b) Schematics of 500 Hz KTP-based OPO laser with an output of 1724 nm. M1,
um dideuterium phosphate Pockels cell; KTP, potassium titanyl phosphate. The inset
 (a) and Ref. [99] (b).
J. Hui et al. / Photoacoustics 4 (2016) 11–21 19sample scanning scheme, the speed of PAM is limited, which
hinders its translation from bench to bedside. However, imaging
speed may be improved by translating the transducer instead of
the sample stage [103].
PAT in the new optical windows offers new opportunities for its
use in biomedicine, but also some particular engineering
challenges. As demonstrated in the previous examples, the ability
to perform either two-color imaging or multispectral tomography
lends the technology to different applications. For instance, a two-
color PAT system for ex vivo breast tumor margin assessment may
be advantageous for a compact mobile system designed for a
clinical setting, whereas multispectral tomography is helpful for
analyzing spectral differences in more complex tissue samples. The
most salient advantage and future direction for vibration-based
PAT though is the enabling of molecular-speciﬁc deep-tissue
imaging applications. Vessels, nerves, and organs that accumulate
pathological levels of lipid are of primary interest in this regard.
Currently, magnetic resonance imaging, X-ray computed tomog-
raphy, and ultrasound are used in the clinic to aid in the diagnosis
and treatment monitoring of lesions, such as those in atheroscle-
rosis and fatty liver disease [104,105]. While magnetic resonance
imaging provides excellent soft tissue contrast and adequate
resolution for these applications, its cost and availability make it an
impractical option in many cases. Ultrasound and PA imaging are
well suited to clinical applications requiring functional and
chemical-selective characterization while providing greater imag-
ing depth than purely optical tomographic techniques. Further-
more, different conﬁgurations involving excitation or detection
outside or within the body expand the capabilities and potential
applications of vibration-based PAT.
Challenges for tomographic imaging, including vibration-based
PAT, are present and require reﬁnements in the engineering of
these systems. Two signiﬁcant challenges for in vivo imaging are
the presence of clutter, or unwanted superﬁcial signal enhance-
ment, and volumetric imaging without motion artifacts. The ﬁrst is
mainly contributed by the distance between the illumination
source and the imaging surface (i.e., the irradiation distance) [104].
The geometry of the illumination source and detector may also
help to alleviate this effect, which degrades the signal to
background ratio. Volumetric imaging provides signiﬁcantly more
morphological and compositional information of large and
complex regions. With handheld two-dimensional array trans-
ducers, it is important that it is stabilized in order to collect three-
dimensional images. Furthermore, gating techniques (i.e., respira-
tion and cardiac gating) can signiﬁcantly reduce motion artifacts
from breathing and vessel motion in small animals, which have
high heart and respiration rates. The integration of gating into PAT
will be critical for future experiments examining complex lesions
and areas of the body where motion is signiﬁcant.
IVPA imaging has become one of the hot topics in the ﬁeld of
biomedical imaging. So far, it has shown great potential for clinical
applications and is undergoing rapid development. To translate the
imaging tool from bench to bedside, several signiﬁcant challenges
need to be resolved. The ﬁrst and most pressing challenge is to
develop a high-pulse-energy (mJ level) laser with a lipid-speciﬁc
wavelength at 1.7 mm and with a pulse repetition rate at 10 kHz
level. The high pulse energy would be large enough, but also under
the ANSI safety limits [106], to ensure effective PA signal
generation even through a thin layer of luminal blood. The high
repetition rate would enable IVPA imaging at high speeds
(30 frames/sec), comparable with the speed of many IVUS
systems. The second one is to design a clinically relevant IVPA
catheter. The catheter should be further miniaturized to 1 mm or
less in diameter for clinical practice, as well as maintain excellent
detection sensitivity. Better sensitivity could help reduce the laser
pulse energy, thus further reducing the challenge for developmentof a high-pulse-energy laser. In addition, a clinically relevant large
animal used as a model for human atherosclerosis is also essential
for the validation of IVPA imaging technology. With this model, the
in vivo IVPA imaging procedure, the detection of lipid-laden
plaques, and the clinical requirements of catheters in pressurized
vessels and blood can be all tested and validated. Ultimately, IVPA
imaging of living patients could have a phenomenal impact on both
diagnosis and treatment of vulnerable plaques. Moreover, it has the
potential to guide coronary stenting during percutaneous coronary
intervention, as well as to stimulate the development of new
cholesterol-lowering and anti-inﬂammatory therapeutics for
atherosclerosis. Indeed, it has the potential to be a life-saving
technology when used in clinical settings.
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